Truist raised the firm’s price target on Guardian Pharmacy (GRDN) to $24 from $22 and keeps a Buy rating on the shares. The firm is ...

Guardian Pharmacy Services, Inc. (“Guardian”) (NYSE: GRDN), one of the nation’s largest long-term care (LTC) pharmacy services companies, today announ ...

Guardian Pharmacy Services, Inc. Class A ( (GRDN)) has released its Q3 earnings. Here is a breakdown of the information Guardian Pharmacy Services, Inc. Class A presented to its investors. Guardian ...

ATLANTA (AP) — ATLANTA (AP) — Guardian Pharmacy Services Inc. (GRDN) on Tuesday reported a loss of $122 million in its third quarter. The Atlanta-based company said it had a loss of $2 per share.

Guardian Pharmacy Services Inc. (GRDN) on Tuesday reported a loss of $122 million in its third quarter. The Atlanta-based company said it had a loss of $2 per share.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

(1) Prior to the Corporate Reorganization and IPO, our share-based compensation expense primarily represented non-cash recognition of changes in the value of Restricted Interest Unit awards, which ...

Guardian is a trusted name in LTC pharmacy, specializing in comprehensive medication management solutions tailored to the ever-evolving needs of care providers. Our network of locally-operated ...

The Guardian has quit the social media platform X. The news organisation announced its decision on Wednesday to stop posting from official editorial accounts on the platform, formerly known as ...